BTCS BTCS 深 沪
已收盘 07-02 16:00:00 美东时间
1.12
0.000
0.00%
华盛通- 最 高1.22
- 今 开1.15
- 成交量 60.71万股
- 最 低 1.115
- 昨 收 1.12
- 总市值 5574.84万
- 52周最高 8.44
- 市盈率 静 --
- 换手率 1.22%
- 52周最低 0.98
- 委 比 46.37%
- 总股本 4977.54万
- 历史最高 10.95
- 量 比 1.01
- 振 幅 9.38%
- 历史最低 0.5243
- 每 手 1
- 风险率 1.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BTCS Appoints Veteran Finance Executive to Board Oversight
BTCS ( ($BTCS) ) has shared an announcement. On July 1, 2026, BTCS Inc. appoint...
07-01 20:50
BTCS shareholders approve 2021 equity plan amendments at annual meeting
BTCS shareholders approve 2021 equity plan amendments at annual meeting BTCS held its annual shareholder meeting on June 8, 2026. Shareholders ratified Forvis Mazars, LLP as independent registered public accounting firm for fiscal year 2026. Investors backed amendments to the 2021 Equity Incentive P
06-09 18:03
纳斯达克BTCS 2026年6月1日发布：首席执行官查尔斯·艾伦近日参加《大商业秀》节目，探讨《清晰度法案》以及企业将如何采用区块链技术
2026年6月1日，纳斯达克比特币证券（NasdaqBTCS）发布消息，其首席执行官查尔斯·艾伦（Charles Allen）近期参加《大商业秀》（The B...
06-01 22:50
BTCS Lowers Shareholder Meeting Quorum in Bylaws Change
An update from BTCS ( ($BTCS) ) is now available. On May 29, 2026, the board of...
06-01 22:31
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Gainers 8x8 (NASDAQ:EGHT) shares increased by 14.5% to $2.76 during Tuesday's ...
05-20 05:05
BTCS Q1 EPS $(1.43) Misses $(0.06) Estimate, Sales $2.147M Miss $4.500M Estimate
BTCS (NASDAQ:BTCS) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(0.06) by 2283.33 percent. This is a 66.28 percent decrease over losses of $(0.86) per share from the same
05-15 21:11
BTCS Q1 revenue rises 27% as DeFi operations expand
BTCS Q1 revenue rises 27% as DeFi operations expand Overview US blockchain infrastructure and DeFi operator's Q1 revenue rose 27% yr/yr, driven by Imperium Gross profit margin improved to 47% as business shifted to higher-margin DeFi operations Net loss widened to $69.1 mln, mainly due to realized a
05-15 20:41
美股大行评级 | 存储分歧大！花旗大砍17%将美光目标价从510降至425美元；Bernstein上调希捷科技目标价从500升至620美元
今日重点评级关注：Maxim Group：上调Theriva Biologics评级至"买入"，目标价1美元；HC Wainwright & Co.：维持Bicara Therapeutics"买入"评级，目标价从40美元升至42美元
04-01 16:34
Bicara Therapeutics To Rally Around 121%? Here Are 10 Top Analyst Forecasts For Tuesday
Top analysts changed outlook on top names. See all changes on analyst ratings page. BTIG & HCW cut price targets, Needham & BMO raised, Baird bcut.
03-31 21:01
